BioCryst Shorts Start to Cover: BioBuzz
BioCryst's fall brings profit taking, while a frustrated bull starts issuing his own press releases.
08:28AM 12/09/09
Cell Therapeutics on Dilution Watch: BioBuzz
CEO spotted in New York with bankers in tow, looking at his wallet.
02:16PM 12/08/09
Ariad, Cephalon Make ASH Splash: BioBuzz
News and highlights from the American Society of Hematology annual meeting.
10:45AM 12/08/09
Hemispherx CEO Buys After Stock Collapse: BioBuzz
Carter's stock purchase hardly instills confidence in Hemispherx's future.
09:56AM 12/08/09
Slowing Swine Bursts BioCryst Bubble: BioBuzz
New study concludes H1N1 activity may not be any worse than seasonal flu.
09:11AM 12/08/09
'Mad Money Lightning Round': Stick With JPMorgan
Cramer says it's the best-run and best-capitalized company.
07:20PM 12/02/09
Cramer's 'Mad Money' Recap: Amazon's Amazing Run (Final)
Cramer says the stock of the Internet retail giant could top $216 next year.
06:34PM 12/02/09
Boise Shareholders Sell $78.6M in Secondary Offering
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
09:38AM 11/24/09
Cel-Sci's History of Disappearing Drugs: BioBuzz
Will Cel-Sci's flu drug last longer than its other fly-by-night projects?
09:20AM 11/24/09
BioCryst Bull Blames Conspiracy for Stock's Fall: BioBuzz
Hedge funds, Wall Street, SEC and FDA out to hurt maker of flu drug, newsletter writer claims.
06:45AM 11/24/09
U.S. Sees Low Demand for BioCryst Flu Drug
Peaking flu season could mean no need for further peramivir orders.
11:12AM 11/18/09
So far, it is just some mild consolidation after a big day yesterday.
10:29AM 11/17/09
Keep an Eye on the Dollar (Top Stocks $)
A number of technical developments in the greenback warrant some scrutiny.
07:29PM 11/16/09



Connect with TheStreet